The notion that NFAT5 is causally linked to these events is supported by the observation that AR is a prototypical NFAT5 target gene [66], and that NFAT5 shows increased DNA binding activity to its consensus sequence in PBMC from patients with diabetic microvascular complications compared with diabetic control subjects under hyperglycemic conditions [62]. Here, NFAT5 is linked to complication.